ClinicalTrials.gg
CompletedNCT07937072Updated Nov 13, 2026

Single Versus Double Hem-o-lok Clip for Appendiceal Stump Closure in Laparoscopic Appendectomy

An interventional study of Laparoscopic appendectomy with Hem-o-lok appendiceal stump closure in Acute Appendicitis, sponsored by Furkan Kilic. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Furkan Kilic · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 years 11 months after the study started (first participant enrolled Dec 2017, registered Nov 2026).
Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
644
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 45 studies in Appendicitis with a site in Turkey — 10 open to participants now, 12 under way, none of them phase 3. Appendicitis · Turkey.

Enrollment
Largest of 25
644 · median 100
Started
2017
with 3 others
No phase
23 of 45
6 open now
Registered
44th of 45
by date

Among the 45 studies in Appendicitis with a site in Turkey, this one has the largest enrollment of the 25 interventional ones that give a count, is one of 4 that started in 2017, is one of 23 with no phase, and was the 44th registered.

Appendicitis

421 studies on the registry are indexed under Appendicitis; 67 are open to participants now.

Browse Appendicitis studies →

Open to participants now

10 of the 45 studies in Appendicitis with a site in Turkey are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 39 Appendicitis studies recruiting now, 18 (46%) set no upper age limit and 19 (49%) stop at 75 or younger; 23 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Appendicitis with a site in Turkey, or all of them as a file.
02

Study summary

This quasi-randomized controlled trial compared the use of a single versus double Hem-o-lok polymer clip for closure of the appendiceal stump during laparoscopic appendectomy in adults with non-perforated acute appendicitis. Patients were allocated according to the parity of their hospital admission protocol number (odd: single clip; even: double clip). The primary outcome was the rate of postoperative complications within six months of surgery, graded according to the Clavien-Dindo classification.

Read the detailed description

Patients undergoing laparoscopic appendectomy for a preliminary diagnosis of acute appendicitis at a single tertiary centre between December 2017 and December 2020 were assessed. A standardised three-port technique with uniform antibiotic prophylaxis was used. Patients with perforated appendicitis, pregnancy, immunosuppression, tubo-ovarian pathology, antibiotic use outside the study protocol, or non-standard operative technique (intra-abdominal lavage, drain placement, non-Hem-o-lok stump closure, or clip number inconsistent with allocation) were excluded. Follow-up visits took place on postoperative days 7 and 30, with a telephone assessment at 6 months. Complications were defined as any deviation from the normal postoperative course within 6 months and graded with the Clavien-Dindo classification. NOTE: This study was registered retrospectively, after completion of follow-up and during peer review of the primary report; registration was not part of institutional practice for investigator-initiated surgical studies at the time the study was designed.

03

Conditions studied

  • Acute Appendicitis

Keywords

  • laparoscopic appendectomy
  • Hem-o-lok
  • appendiceal stump closure
  • polymer clip
  • postoperative complications
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Preliminary diagnosis of acute appendicitis
  • Laparoscopic appendectomy completed with Hem-o-lok appendiceal stump closure
  • Standardised operative technique as per protocol

Exclusion criteria

Exclusion Criteria:

  • Perforated appendicitis (intraoperative or histopathological)
  • Pregnancy
  • (including systemic use)
  • Tubo-ovarian pathology
  • Antibiotic use outside the study protocol
  • Intra-abdominal lavage or drain placement
  • Non-Hem-o-lok stump closure or clip number inconsistent with allocation
  • Loss to follow-up
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
644 participants (actual)

Study arms

  • Active comparator
    Single clip

    Appendiceal stump closed with a single Weck Hem-o-lok XL non-absorbable polymer clip (Teleflex Inc., Wayne, PA, USA). Patients with odd admission protocol numbers.

    Procedure: Laparoscopic appendectomy with Hem-o-lok appendiceal stump closure

  • Active comparator
    Double clip

    Appendiceal stump closed with two Weck Hem-o-lok XL non-absorbable polymer clips. Patients with even admission protocol numbers.

    Procedure: Laparoscopic appendectomy with Hem-o-lok appendiceal stump closure

Interventions

  • ProcedureLaparoscopic appendectomy with Hem-o-lok appendiceal stump closure

    Standardised three-port laparoscopic appendectomy; stump closure with one or two Hem-o-lok XL polymer clips according to allocation; specimen extraction with an endobag; no intra-abdominal lavage, no drain.

06

What researchers measure

Primary outcomes

  1. Postoperative complications

    Any deviation from the normal postoperative course, recorded regardless of its relation to the stump closure technique and graded according to the Clavien-Dindo classification.

    Time frame: 6 months after surgery

Secondary outcomes

  1. Appendiceal stump leak or dehiscence

    Time frame: 6 months

  2. Hem-o-lok clip migration or erosion into the gastrointestinal tract

    Time frame: 6 months

  3. Surgical site infection

    Superficial incisional, deep incisional or organ/space infection

    Time frame: 6 months

  4. Reoperation for a postoperative complication

    Time frame: 6 months

07

Study locations

1 site
  • Istanbul Medeniyet University Goztepe Training and Research Hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — The datasets generated and analysed during the study are available from the corresponding author on reasonable request.

Supporting information: Analytic code

Time frame: Beginning after publication of the primary results, with no end date determined.

Access criteria: Reasonable request to the corresponding author.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2017 to primary completion in Jun 2021, 42 months.

Of 92 non-industry interventional studies with no phase under Appendicitis, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's 42 months is above that.

Counting every sponsor, half of 94 studies reached it within 19 months; a quarter within 10 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 13, 2026
StartActual
Dec 1, 2017
Primary completionActual
Jun 30, 2021
CompletionActual
Jun 30, 2021
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937072
Lead sponsor
Furkan Kilic
Responsible party
Furkan Kilic (MD, Istanbul Medeniyet University) — Sponsor-investigator
First posted
Nov 13, 2026
Start date
Dec 1, 2017
Primary completion
Jun 30, 2021
Completion
Jun 30, 2021
Last update
Nov 13, 2026

Study contacts

Orhan Alimoglu, MD
study chair · Istanbul Medeniyet University, Faculty of Medicine, Department of General Surgery, Istanbul, Türkiye
Furkan Kilic, MD
principal investigator · Istanbul Medeniyet University, Faculty of Medicine, Department of General Surgery, Istanbul, Türkiye

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion